Select a Region North America

EVERSANA President Greg Skalicky Named to Prestigious 2024 PharmaVoice 100 List

CHICAGO – October 8, 2024 – EVERSANA, a leading provider of global commercial services to the life sciences industry life sciences industry, today announced that Greg Skalicky, President, has been named a 2024 PharmaVoice 100 winner. This annual list recognizes the most inspiring people in the life sciences industry.

Skalicky, a pharmaceutical industry veteran with more than 30 years of experience in both clinical and commercial operations, has been recognized in the “Standout Leader” category. A proven innovator and previous PharmaVoice 100 honoree in 2014, Skalicky has led the transformation of commercialization models in the life sciences industry. Since joining EVERSANA he spearheaded the company’s efforts to concept, develop, and deliver multiple commercialization models, including EVERSANA COMPLETE Commercialization and EVERSANA COMPLETE Oncology, to accelerate client value and improve health outcomes. Beyond his leadership in EVERSANA’s global expansion, Skalicky leads the operational success of all client commercialization programs, including multiple product launches for clients each year.

“Greg’s energy and commitment to advancing commercialization has propelled EVERSANA to where we are today,” said Jim Lang, CEO, EVERSANA. “We’ve delivered on our promise to transform commercialization and improve the life sciences sector – all to the benefit of clients, patients and providers.”

PharmaVoice100 honorees are selected from nominations submitted by readers and colleagues, which are evaluated by the PharmaVoice team and then categorized into 10 distinct groups: Standout Leaders, Cancer Care Visionaries, Cardiometabolic All-Stars, Trailblazers, Biotech Pathfinders, Rare Disease Warriors, Tech and AI Wizards, Clinical Trial Pros, Patient Champions, and Cell and Gene Therapy Pioneers. Each winner represents the transformative impact of the pharmaceutical industry in their own unique way.

Since 2005, the PharmaVoice 100 has become one of the publication’s most anticipated features. From academia and nonprofits to Big Pharma, startups and tech companies, it is the only awards program in the industry that honors individuals from all sectors of life sciences. These honorees, from the clinic to the C-suite, are making meaningful contributions to their fields and striving to improve outcomes for patients around the world.

A complete list of the 2024 winners can be found here.

 

About EVERSANA®

EVERSANA® is a leading provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X.

 

MEDIA CONTACT

 

Matt Braun
Vice President, Corporate Communications
E-mail: [email protected]